Percutaneous Coronary Intervention in Patient with Protein C Deficiency
Keywords:
Acute STEMI, Protein C deficiency, Percutaneous Coronary InterventionAbstract
The incidence of acute STEMI in patients with protein C deficiency is rare. Treatment of acute STEMI in patients with coagulation disorders is like that of the general population. Medication after the occluded artery has been performed by balloon and stent placement, especially for patients who take direct oral anticoagulants (DOACs) and still have thromboembolism. It is something that needs to be planned for treatment and further study.
References
Sugiyama T, Hasegawa K, Kobayashi Y, Takahashi O, Fukui T, Tsugawa Y. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011. J Am Heart Assoc. 2015; 4 (3): e001445. https://doi.org/10.1161/JAHA.114.001445
McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011; 124 (1): 40-7. https://doi.org/10.1016/j.amjmed.2010.07.023
Thai Acute Coronary Syndromes Guidelines 2020; Sep 2020: 1-63.
Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med. 1986; 314:1298-304. https://doi.org/10.1056/NEJM198605153142006
Karpatkin M, Mannuccio Mannucci P, Bhogal M, et al. Low protein C in the neonatal period. Br J Haematol. 1986; 62:137-42. https://doi.org/10.1111/j.1365-2141.1986.tb02909.x
Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987; 317: 991-6. https://doi.org/10.1056/NEJM198710153171604
Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998; 92: 2353-8. https://doi.org/10.1182/blood.V92.7.2353
Bauer KA. Coumarin-induced skin necrosis. Arch Dermatol. 1993; 129: 766-8. https://doi.org/10.1001/archderm.1993.01680270104015
Pourdeyhimi N, Bullard Z. Warfarininduced skin necrosis. Hosp Pharm. 2014; 49: 1044-8. https://doi.org/10.1310/hpj4911-1044
Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996; 348: 913-6. https://doi.org/10.1016/S0140-6736(96)04125-6
Marlar RA, Mastovich S. Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis, and treatment. Blood Coagul Fibrinolysis. 1990 Aug; 1 (3): 319-30. https://doi.org/10.1097/00001721-199008000-00010
Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017 Jan; 43 (1): 24-30. https://doi.org/10.1007/s11239-016-1428-2
Sottiurai VS. Comparison of surgical modalities in the treatment of recurrent venous ulcer. Int Angiol. 1990 Oct-Dec; 9 (4): 231-5.
Maroko PR, Libby P, Ginks WR, et al. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest. 1972; 51: 2710-6. https://doi.org/10.1172/JCI107090
Vogel B, Claessen BE, Arnold SV, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers. 2019 Jun 6; 5 (1): 39. https://doi.org/10.1038/s41572-019-0090-3
Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017 Mar 14; 38 (11): 774-84.
Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022 Feb 15; 327 (7): 662-75. https://doi.org/10.1001/jama.2022.0358
Kulahcioglu S, Ayturk M, Sari M. Multiple thrombotic sources and embolic events at arterial sites in a patient with protein C deficiency. Blood Coagul Fibrinolysis. 2021 Dec 1; 32 (8): 607-10. https://doi.org/10.1097/MBC.0000000000001063
Yaarubi RA, Rawahi BA, Lawati HA. Protein C deficiency presenting as an acute infero-posterior ST elevation myocardial infarction in a young man; A case report and focused literature review. Thromb Res. 2020 Aug; 192: 109-12. https://doi.org/10.1016/j.thromres.2020.05.026
van den Belt AG, Hutten BA, Prins MH, Bossuy PM. Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S-a decision analysis. Thromb Haemost. 2000 Nov; 84 (5): 758-63. https://doi.org/10.1055/s-0037-1614111
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
